Get started
Author

Russell T. Villanueva

Observed names: R. Villanueva, Russel Villanueva, Russell VILLANUEVA, Russell Vilanueva, Russell Villanueva, Villanueva, Russell
ORCID: 0000-0002-3515-5366
Observed ORCID: 0000-0002-3515-5366
OpenAlex ID: A5021206220
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial
2024 · Jonathan Barratt, Adrian Liew, et al. · Clinical Journal of the American Society of Nephrology · 90
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial
2025 · Michael Walsh, David Collister, et al. · The Lancet · 50
PDF
Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease
2020 · Adrian LIEW, Sunita BAVANANDAN, et al. · Nephrology · 24
Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease – An Executive Summary
2020 · Adrian Liew, Sunita Bavanandan, et al. · Nephrology · 21
PDF
Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease – Executive Summary
2020 · Adrian LIEW, Sunita BAVANANDAN, et al. · Nephrology · 20
Coding practice in national and regional kidney biopsy registries
2021 · On behalf of the Kidney Biopsy Codes for Pathologists project (www.kibico.org), Amélie Dendooven, et al. · BMC Nephrology · 19
PDF
Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis
2023 · Phil McEwan, Marco Hafner, et al. · Journal of Medical Economics · 9
Impact of Age Difference, Sex Matching, and Body Mass Index Matching Between Donor and Recipient in Renal Transplant
2019 · Abubakar T. Baddiri, Russell T. Villanueva, et al. · Transplantation Proceedings · 7
The Aldosterone Blockade for Health Improvement Evaluation in End-Stage Renal Disease (ACHIEVE) Trial: Rationale and Clinical Research Protocol
2025 · Michael Walsh, David Collister, et al. · Canadian Journal of Kidney Health and Disease · 6
Emerging Role of Sodium–Glucose Co-Transporter 2 Inhibitors for the Treatment of Chronic Kidney Disease
2023 · Rey Isidto, Romina Danguilan, et al. · International Journal of Nephrology and Renovascular Disease · 3
PDF
Mo727effect of Sacubitril/valsartan on Serum Potassium and Blood Pressure Levels of Dialysis Patients With Heart Failure
2021 · Renee Mari Gula, Marichel Coronel, et al. · Nephrology Dialysis Transplantation · 2
Association of Mesangial Hypercellularity, Endocapillary Hypercellularity, Segmental Sclerosis, Tubular Atrophy, and Crescent Formation (MEST-C)-Based Steroid Response Scores with Kidney Prognosis in Patients with IgAN at the National Kidney and Transplant Institute (NKTI): A Retrospective Cohort Study from January 2018 to December 2023
2026 · Maria Cristina Amat, Russell T. Villanueva · Journal of the American Society of Nephrology
WCN26-6808 EFFECT OF SIBEPRENLIMAB ON MICROSCOPIC HEMATURIA IN ADULTS WITH IgA NEPHROPATHY: INTERIM ANALYSIS OF THE “VISIONARY” PHASE 3 TRIAL
2026 · Hitoshi Suzuki, Vivek Jha, et al. · Kidney International Reports
Pos-182 Serologic and Urinary Characteristics of Laboratory-confirmed Genitourinary Tuberculosis at a Tertiary Hospital in the Philippines
2021 · P.N. SO, R. Villanueva · Kidney International Reports
PDF
Works count: 20
Citation count: 351
H-index: 9
I10-index: 8
Year
Topic
Type